Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3024% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker Orthopaedics — Segment Revenue by Quarter
Orthopaedics — Segment Revenue ($M) ($M)
Stryker Orthopaedics — Segment Revenue: $2,856M in Q3 2026, up 26.7% from a year earlier.
Latest, Q3 2026
2,856
Period ended Sep 30, 2026
Change on a year earlier
+26.7%
2,254 in Q3 2025
History
43 quarters
Since Q1 2016
Sources
32
Documents cited below
Where the Q3 2026 figure comes from
Source: Stryker Form 10-Q — FY2026Q3 (filed 2026-10-30) ↗
Reported in Postgres DB segment_values + FY2026Q3 Form 10-Q XBRL.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up orthopaedics — Segment Revenue
Cite this data
StockData. (2026). Stryker Orthopaedics — Segment Revenue ($M), quarterly Q1 2016–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/db-seg-or-rev
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.